XML 108 R70.htm IDEA: XBRL DOCUMENT v3.25.0.1
Significant agreements - Cancer Research UK (Details)
$ in Thousands
12 Months Ended
Dec. 04, 2024
GBP (£)
Dec. 13, 2016
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Research and development arrangement obligation to repay other parties        
Contingent future milestones payments under research and development arrangement   $ 50,900    
Gain on extinguishment of research and development funding liability     $ 4,476  
BT1718        
Research and development arrangement obligation to repay other parties        
Liability from research and development       $ 4,300
Research and Development Arrangement, Upfront Cash Payment | £ £ 50,000      
Gain on extinguishment of research and development funding liability     $ 4,500  
BT1718 | Minimum        
Research and development arrangement obligation to repay other parties        
Tiered royalties (percentage)   70.00%    
BT1718 | Maximum        
Research and development arrangement obligation to repay other parties        
Tiered royalties (percentage)   90.00%